Concepedia

Mark S. Watkins

MS

Statistics

Publications

2

Citations

43

H-Index

2

Active since

2019

Affiliations

GlaxoSmithKline (United States)(Current)

Mark S. Watkins is an author at GlaxoSmithKline (United States) specializing in allergy, immunosuppression, and complement system.

Top concepts

Publications per year

2019–2020

2

Publications

2

Carcinogenicity Assessment of Daprodustat (GSK1278863), a Hypoxia-Inducible Factor (HIF)-Prolyl Hydroxylase Inhibitor

David F. Adams, Mark S. Watkins, Luc Durette et al. · Toxicologic Pathology · 2019 · 27 citations

Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates

Susan Laffan, Andrew S. Thomson, Shing Mai et al. · PLoS ONE · 2020 · 16 citations · Full text

, , +19

1–2 of 2